Seladin-1 as a target of estrogen receptor activation in the brain: A new gene for a rather old story?

Journal of Endocrinological Investigation

Volumn 28, Issue 5, 2005, Pages 285-293

  Peri, A ^a   Danza, G ^a   Serio, M ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Alzheimer's disease; DHCR24; Estrogen; Seladin 1; Selective estrogen receptor modulators

Indexed keywords

AMYLOID BETA PROTEIN; BRASSINOLIDE; CASPASE 3; CASPASE 3 INHIBITOR; DESMOSTEROL; ESTROGEN RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; VEGETABLE PROTEIN; 3BETA HYDROXYSTEROL DELTA24 REDUCTASE; 3BETA-HYDROXYSTEROL DELTA24-REDUCTASE; ARABIDOPSIS PROTEIN; DHCR24 PROTEIN, HUMAN; DIM1 PROTEIN, ARABIDOPSIS; NERVE PROTEIN; NEUROPROTECTIVE AGENT; OXIDOREDUCTASE;

ALZHEIMER DISEASE; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME INHIBITION; ESTROGEN THERAPY; GENE; GENE EXPRESSION; HUMAN; NEUROPROTECTION; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; POSTMENOPAUSE; REVIEW; SELADIN 1 GENE; BRAIN; FEMALE; GENETICS; PHYSIOLOGY;

ALZHEIMER DISEASE; ARABIDOPSIS PROTEINS; BRAIN; FEMALE; HUMANS; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; RECEPTORS, ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 21444461433     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03345387     Document Type: Review

References (45)

1. Wise PM. Estrogens and neuroprotection. Trends Endocrinol Metab 2002, 13: 229-30.
2. Behl C. 2003 Estrogen can protect neurons: modes of action. J Steroid Biochem Mol Biol 2002, 83: 195-7.
3. Maggi A, Ciana P, Belcredito S, Vegeto E. Estrogens in the nervous system: mechanisms and nonreproductive functions. Ann Rev Physiol 2004, 66: 291-313.
4. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001, 81: 741-76.
5. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994, 140: 256-61.
6. Fillit HM. The role of hormone replacement therapy in the prevention of Alzheimer's disease. Arch Intern Med 2002, 162: 1934-42.
7. Hogervorst E, Williams J, Budge M, Riedel W, Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 2000, 101: 485-512.
8. MacLusky NJ. Estrogen and Alzheimer's disease: the apolipoprotein connection. Endocrinology 2004, 145: 3062-4.
9. Brinton RD. Impact of estrogen therapy on Alzheimer's disease: a fork in the road? CNS Drugs 2004, 18: 405-22.
10. Zandi PP, Carlson MC, Plassman BL et al. Hormone replacement therapy and incidence of Alzheimer disease in older women. JAMA 2002, 288: 2123-9.
11. Resnick SM, Henderson VW. Hormone therapy and risk of Alzheimer disease. JAMA 2002, 288: 2170-2.
12. Dubal DB, Zhu H, Yu J et al. Estrogen receptor alpha, not beta, is a critical link in esradiol-mediated protection against brain injuery. Proc Natl Acad Sci USA 2001, 98: 1952-7.
13. Hu XY, Qin S, Lu YP, Ravid R, Swaab DF, Zhou JN. Decreased estrogen receptor-α expression in hippocampal neurons in relation to hyperphosphorylated tau in Alzheimer patients. Acta Neuropathol 2003, 106: 213-20.
14. Wang L, Andersson S, Warner M, Gustafsson JA. Morphological abnormalities in the brains of estrogen receptor beta knockout mice. Proc Natl Acad Sci USA 2001, 98: 2792-6.
15. Hawkins MB, Thornton JW, Crews D, Skipper JK, Dotte A, Thomas P. Identification of a third distinct estrogen receptor and reclassification of estrogen receptors in teleosts. Proc Natl Acad Sci USA 2000, 97: 10751-6.
16. Toran-Allerand CD. Minireview: a plethora of estrogen receptors in the brain: where will it end? Endocrinology 2004, 145: 1069-74.
17. Dhandapani KM, Brann DW. Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biol Reprod 2002, 67: 1379-85.
18. O'Neill K, Chen S, Brinton RD. Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease. Exp Neurol 2004, 185: 63-80.
19. O'Neill K, Chen S, Brinton RD. Impact of the selective estrogen receptor modulator, tamoxifen, on neuronal outgrowth and survival following toxic insults associated with aging and Alzheimer's disease. Exp Neurol 2004, 188: 268-78.
20. Yaffe K, Krueger K, Sarkar S et al. Cognitive function in post-menopausal women treated with raloxifene. N Engl J Med 2001, 344: 1207-13.
21. Greeve I, Hermans-Borgmeyer I, Brellinger C, et al. The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J Neurosci 2001, 20: 7345-52.
22. Iivonen S, Hiltunen M, Alafuzoff I, et al. Seladin-1 transcription is linked to neuronal degeneration in Alzheimer's disease. Neuroscience 2002, 113: 301-10.
23. Sarkar D, Imai T, Kambe F, et al. The human homolog of Diminuto/Dwarf1 gene (hDiminuto): a novel ACTH-responsive gene overexpressed in benign cortisol-producing adrenocortical adenomas. J Clin Endocrinol Metab 2001, 86: 5130-7.
24. Luciani P, Ferruzzi P, Arnaldi G et al. Expression of the novel ACTH-responsive gene seladin-1/DHCR24 in the normal adrenal cortex and in adrenocortical adenomas and carcinomas. J Clin Endocrinol Metab 2004, 89: 1332-9.
25. Wu C, Miloslavskaya I, Demontis S, Maestro R, Galaktionov K. Regulation of cellular response to oncogenic and oxidative stress by Seladin-1. Nature 2004, 432: 640-5.
26. FitzPatrick DR, Keeling JW, Evans MJ et al. Clinical phenotype of desmosterolosis. Am J Med Genet 1998, 75: 145-52.
27. Waterham HR, Koster J, Romeijn GJ et al. Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am J Hum Genet 2001, 69: 685-94.
28. Herman GE. Disorders of cholesterol biosynthesis: prototypic metabolic malformation syndromes. Hum Mol Genet 2003, 12 Spec No 1: R75-88.
29. Yanagisawa K. Cholesterol and pathological processes in Alzheimer's disease. J Neurosci Res 2002, 70: 361-6.
30. Puglielli L, Tanzi RE, Kovacs DM. Alzheimer's disease: the cholesterol connection. Nat Neurosci 2003, 6: 345-51.
31. Reiss AB, Siller KA, Rahman MM, Chan ES, Ghiso J, de Leon MJ. Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease. Neurobiol Aging 2004, 25: 977-89.
32. Arispe N, Doh M. Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AbetaP (1-40) and (1-42) peptides. FASEB J 2002, 16: 1526-36.
33. Wechsler A, Brafman A, Shafir M et al. Generation of viable cholesterol-free mice. Science 2003, 302: 2087.
34. Rothblat GH, Burns CH, Conner RL, Landrey JR. Desmosterol as the major sterol in L-cell mouse fibroblasts grown in sterol-free culture medium. Science 1970, 169: 880-2.
35. Schumacher K, Chory J. Brassinosteroid signal transduction: still casting the actors. Curr Opin Plant Biol 2000, 3: 79-84.
36. Clouse SD, Sasse JM. BRASSINOSTEROIDS: Essential Regulators of Plant Growth and Development. Annu Rev Plant Physiol Plant Mol Biol 1998, 49: 427-51.
37. Klahre U, Noguchi T, Fujioka S et al. The Arabidopsis DIMINUTO/DWARF1 gene encodes a protein involved in steroid synthesis. Plant Cell 1998, 10: 1677-90.
38. Clouse SD. Arabidopsis mutants reveal multiple roles for sterols in plant development. Plant Cell 2002, 14: 1995-2000.
39. Choe S, Dilkes BP, Gregory BD et al. The Arabidopsis dwarf1 mutant is defective in the conversion of 24-methylenecholesterol to campesterol in brassinosteroid biosynthesis. Plant Physiol 1999, 119: 897-907.
40. Suzuki M, Kamide Y, Nagata N et al. Loss of function of 3-hydroxy-3-methylglutaryl coenzyme A reductase 1 (HMG1) in Arabidopsis leads to dwarfing, early senescence and male sterility, and reduced sterol levels. Plant J 2004, 37: 750-61.
41. Lutjohann D, Brzezinka A, Barth E et al. Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain. J Lipid Res 2002, 43: 1078-85.
42. Vannelli GB, Ensoli F, Zonefrati R et al. Neuroblast long-term cell cultures from human fetal olfactory epithelium respond to odors. J Neurosci 1995, 15: 4282-94.
43. Barni T, Maggi M, Fantoni G et al. Sex steroids and odorants modulate gonadotropin-releasing hormone secretion in primary cultures of human olfactory cells. J Clin Endocrinol Metab 1999, 84: 4266-73.
44. Benvenuti S, Luciani P, Vannelli GB et al. Estrogen and SERMs exert neuroprotective effects and stimulate the expression of seladin-1, a recently discovered anti-apoptotic gene, in human neuroblast long-term cell cultures. J Clin Endocrinol Metab 2005, 90: 1775-82.
45. Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, Katzenellenbogen BS. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol 2003, 206: 13-22.